Position in PFE
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$336,173
+$9,909 QoQ
Shares Held
11,972
-8.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Reynders McVeigh Capital Management, LLC holds $48,961,420 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
76,014 | $18,580,862 | |
| 2 | NVS |
Novartis AG
|
73,392 | $11,210,628 | |
| 3 | ABBV |
AbbVie Inc.
|
29,052 | $6,318,519 | |
| 4 | LLY |
ELI LILLY & Co
|
5,986 | $5,505,743 | |
| 5 | AMGN |
Amgen Inc
|
9,182 | $3,230,686 | |
| 6 | MRK |
Merck & Co., Inc.
|
22,387 | $2,692,932 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,904 | $1,085,877 | |
| 8 | PFE |
Pfizer Inc
This page
|
11,972 | $336,173 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $336,173 | 11,972 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $326,264 | 13,103 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $404,444 | 15,873 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $431,665 | 17,808 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $491,950 | 19,414 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $566,309 | 21,346 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $635,117 | 21,946 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $555,291 | 19,846 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $593,322 | 21,381 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $626,211 | 21,751 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $960,603 | 28,960 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,238,940 | 33,777 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,448,522 | 35,503 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,659,458 | 32,386 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,546,128 | 35,332 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,754,989 | 33,473 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,922,013 | 37,126 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,277,794 | 38,574 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,680,572 | 39,074 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,516,157 | 38,717 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,157,858 | 59,560 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,924,132 | 52,272 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,160,490 | 58,869 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,050,913 | 62,719 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,098,814 | 64,302 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||